Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Copley Pharmaceutical

This article was originally published in The Gray Sheet

Executive Summary

Announces agreement with Ocular Research of Boston under which it gains exclusive worldwide rights to manufacture and market a series of new ophthalmic solutions developed and patented by ORB. The new over-the-counter solutions include "lubricating and rewetting solutions" for prescription contact lenses as well as "artificial tear preparations." A single PMA application was filed this year for the solutions, which can be used with or without contact lenses; profits from sales will be split between the two companies. The solutions use "specialized lipids, including phospholipids, to reconstruct and thicken the tear film" to prevent drying of the eyes without blurring vision.
UsernamePublicRestriction

Register

MT000397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel